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A b s t r a c t  
Lactic acid fermentation and not oxidative phosphorylation is reported to be one of the major 
bioenergetics mechanisms by which cancer cells thrive and proliferate with such rapidity in non-
ambient hypoxic conditions. The objective of the study was to determine the synergistic effect of 
spices in a decoction; Turmeric (Curcuma longa), Pepper (Piper nigrum) and Garlic (Allium 
sativum) in combination, on the metabolism of Hep G2 liver cancer cells. The biochemical 
studies of 2 major enzymes involved in cellular metabolism of cells namely; Pyruvate 
dehydrogenase (PDH) and Lactate dehydrogenase A (LDHA) showed that the decoction down 
regulated the activity of LDHA and increased the activity of PDH in cancer cells, thereby shifting 
the metabolic mechanism towards normal functioning in the cancer cells. The expression studies 
of major molecules involved in regulating metabolic machinery in cells viz., tumour suppressor 
p53 and oncogene MYC mRNAs; and western blot analysis of Hypoxia inducible factor-1-alpha 
(HIF-1α) and Vascular endothelial growth factor (VEGF) showed that the decoction regulated 
the expression of these factors helping to revert the metabolism in cancer cells, which could be 
attributed to the effect of turmeric and also garlic, rich in pantothenic acid, that aids in turning on 
oxidative phosphorylation in cancer cells. With the above results, it could be concluded that the 
decoction alters the metabolic mechanism in a cancer cell from lactic acid fermentation to 
oxidative phosphorylation, like in any other normal cell, thus inhibiting further growth of the 
cancer. 
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Introduction 
One of the major differences between a normal cell and a cancer cell 
is the ability of the cancer cell to survive and flourish in severely 
hostile and harsh conditions. This adroitness of the cancer cell can 
be attributed to many factors, one of the most prominent being, the 
capability to shift its basic bioenergetics mechanism from oxidative 
phosphorylation to aerobic glycolysis followed by lactic acid 
fermentation. This shift is mainly triggered by critical changes in the 
microenvironment of the cell, resulting from inadequate supply of 
oxygen and hypoxia [1]. The hypoxic environment results in 
aggressive and metastatic cancer phenotypes which are associated 
with resistance to radiation therapy, chemotherapy and a poor 
prognosis [2]. The responses to hypoxia are highly dependent on the 
activation of hypoxia inducible factor-1-alpha (HIF-1α) [3]. HIF-1α 
trans-activates a large number of genes that are involved in cellular 
processes, such as glucose uptake and metabolism, angiogenesis, 
cell proliferation, differentiation and apoptosis [4, 5]. Over expression 
of HIF-1α also plays a major role in initiating lactic acid fermentation 
in cancer cells by modulating the activity of tumor suppressor p53 
and oncogene MYC and through the overexpression of VEGF, which 
stimulates angiogenesis in tumor microenvironment. 
Natural products from plants have played a crucial role in lives of 
humans especially as source of food and medicines throughout 
history. The anti-tumour compounds act by several mechanisms 
such as inducing apoptosis (programmed cell death) through DNA 
cleavage mediated by topoisomerase I or II inhibition, mitochondrial 
permeabilization, inhibition or regulation of key enzymes involved in 
signal transduction (e.g. proteases), or cellular metabolism, and by 
inhibiting tumour-induced angiogenesis (recruitment of new blood 
vessels) [6]. Curcumin, a major active component of turmeric has 
been shown to decrease HIF-1α in hepatocellular carcinoma cells 
[7]. Black pepper is rich in piperine, which is found to increase the 
bioavailability of curcumin along with possessing anticancer activity 
against many cancer types. Garlic has been found to be rich in 
Vitamin B5 (Pantothenic acid) which is a precursor for the formation 
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of Acetyl Co-A and has also been reported to possess anti-tumor 
activity. 
The decoction used for our study comprises of Curcuma longa, Piper 
nigrum and Allium sativum added in equal parts, which is part of daily 
culinary use all over the world. The objective of this study is to 
determine the synergistic effect of the spices in the decoction on 
regulation of the bioenergetics mechanism in liver cancer cell line, 
Hep G2 by focussing on, the activity of enzymes namely pyruvate 
dehydrogenase and lactate dehydrogenase A and molecular factors 
viz., p53, MYC, HIF-1α and VEGF. 
 
Materials and Methods 
 
Preparation of the decoction 
 
Dried powder of, rhizome of Curcuma longa , bulb of Allium sativum 
and fruits of Piper nigrum were taken in equal parts (10 mg each) 
together (30 mg) in 30 mL water and mixed well using mortar and 
pestle. The decoction was then heated at 100ºC for 10 minutes, 
diluted to different concentrations with distilled water and filtered 
through Whatmann filter paper (No: 4) and was used for the assays. 
 
Cell culture and treatment 
 
The Human liver cancer (Hep G2) and normal (Chang Liver cells) 
cells were obtained from NCCS, Pune. The cells were maintained in 
DMEM supplemented with 10 % FBS 75 and 100 mg/L streptomycin 
and 100 U/L penicillin. Cells were maintained at 37ºC in a humidified 
atmosphere of 5 % CO2 and 95 % air. All cell culture reagents were 
purchased from Hi-media (Mumbai, India). 
 
Enzyme assays 
 
Pyruvate dehydrogenase (PDH) activity assay 
 
Pyruvate dehydrogenase activity was measured using a modified 
protocol of Prabhu et al., (2014) [8]. Rapidly homogenize the Hep G2 
cells (1 x 106) untreated control and decoction treated (7.5, 15 and 
30 µg/mL), with 100 µL ice cold PDH assay buffer and keep on ice 
for 10 min. Centrifuge this at 10,000 x g for 5 min. Transfer the 
supernatant to a fresh tube. Take 50 µL samples for the assay along 
with 46 µL of PDH assay buffer, 2 µL PDH developer and 2 µL PDH 
substrate. Absorbance was measured at 450 nm for 10-60 min at 
37oC. The PDH activity was calculated according to the formula: 
Pyruvate dehydrogenase activity (mU/mL) = B/(ΔT x V) X D 
where: B = NADH amount; ΔT = reaction time; V = sample volume 
added and D = dilution factor. 
 
Lactate dehydrogenase A (LDHA) activity assay 
 
LDH activity was measured according to a modified protocol of Wang 
et al., (2013) [9]. The assay was based on the detection of absorption 
value of β-NADH at 340 nm, in vitro LDHA enzymatic system was 
established. In a 3 ml reaction mix, the final concentrations were 100 
mM sodium phosphate, 0.12 mM β-NADH, 2.3 mM pyruvate, 0.033% 
(W/V) bovine serum albumin and 20 mg of total protein extracts in 
untreated control or decoction-treated (7.5, 15 and 30 µg/mL) Hep 
G2 cancer cells. The value of absorbance at 340 nm was 
continuously recorded for 5 mins at 37oC. The LDHA activity was 
calculated according to the formula: 
LDH activity (U/mg) = (Test A340 nm/ min – Blank A340 nm/min) x 
3 x df/6.22 x 0.1 x PC 
where: 3 is the total volume of assay, df is the dilution factor, 6.22 is 
the mM extinction coefficient of β-NADH at 340 nm, 0.1 is the volume 
of added protein extracts and PC is the protein concentration. 
 
Cell Viability Assay 
 
The cells were grown in 12-well culture plates. MTT assay was used 
to assess cell viability according to the manufacturer’s instructions 
(Sigma-Aldrich, St. Louis, MO, USA). The assay was quantitated by 
measuring the absorbance at 570 nm [10]. Chang Liver cells were 
used as control (noncancerous cells) to check the activity of the 
decoction on normal cells. After measuring the absorbance at 570 
nm at the end of the MTT assay, the % growth inhibition was 
determined using the formula: 
 
% growth Inhibition = 100 – (Abs (sample) / Abs (control) X 100) 
 
Reverse Transcriptase-PCR 
 
The mRNA expression levels of p53 and MYC were studied using 
reverse-transcriptase PCR [11, 12]. The Hep G2 cells were grown in 
60 mm culture plates. The first set of Hep G2 cells was untreated 
and taken as control. The second set of cells was treated with the 
decoction at 7.5 µg/mL concentration. The third set of cells was 
treated with 15 µg/mL decoction and the last fourth set of cells was 
treated with 30 µg/mL decoction. After incubation, total RNA was 
isolated from the treated and untreated cells using manufacturer’s 
protocol (Chromous Biotech Ltd, Bangalore, India). cDNA was 
synthesized from 1 µg of total isolated RNA by incubation for 1 h at 
37oC with M-MLV reverse transcriptase (Promega, Madison, WI). 
After the 1 h incubation, the mixture was again incubated at 700C for 
15 minutes to deactivate the reverse transcriptase. The cDNA 
synthesized (2 µL) was added with 5 µL reaction buffer (1X), 2 µL 
dNTPs (0.2 mM each), 1 µL each of Forward and Reverse primer 
(0.4 µM each), 3 µL MgCl2, 0.2 µL Taq polymerase (Promega, 
Madison, WI, USA) and made up to 20 µL with nuclease free water 
for PCR reaction. Human specific primers were used for p53, MYC 
and beta-actin. The forward and reverse primers used for p53, MYC 
and beta-actin amplification are given in table. 1. The synthesized 
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PCR products were separated on 1.5 % agarose gels and analyzed 
using ChemiDoc XRS (Bio-Rad Laboratories Inc., Hercules, CA). 
 
Table. 1. Forward and reverse primers for the genes 
Genes Forward primer (5′ - 3′) Reverse primer (5′ - 3′) 
p53 AACGGTACTCCGCCACC CGTGTCACCGTCGTGGA 
MYC AATGAAAAGGCCCCCAAGGTAGTTATCC GTCGTTTCCGCAACAAGTCCTCTTC 
β-actin GTTTGAGACCTTCAACACCCC GTGGCCATCTCCTGCTCGAAGTC 
 
 
Western blot analysis 
 
The protein expression levels of Hypoxia inducible factor-1α (HIF-
1α) and Vascular endothelial growth factor (VEGF) were studied 
using western blotting assay. The Hep G2 cells were grown in 60 
mm culture plates. The first set of Hep G2 cells was untreated and 
was taken as control. The second set of cells was treated with 
decoction at 7.5 µg/mL concentration. The third set of cells was 
treated with decoction at 15 µg/mL and the last fourth set of cells 
was treated with decoction at 30 µg/mL concentrations. The protein 
was separated by SDS-PAGE on a 10 % separating gel and 
transferred to nitrocellulose membrane [13, 14]. Addition of primary 
mouse monoclonal anti-HIF-1α and rabbit polyclonal anti-VEGF 
antibodies were done after the transfer of protein on to the 
membrane. The nonspecific protein binding sites on the blotted 
nitrocellulose membrane were blocked with 5% non-fat dry milk in 
0.1 % Tween-20 in PBS (pH 7.4) at 4°C overnight. The membrane 
was incubated with monoclonal antibodies for HIF-1α, VEGF and β-
actin at the dilution of 1:500 (in 3 % BSA), 1:2000 (in 3 % BSA) and 
1:2000 (in 3 % BSA) respectively at 40C overnight with gentle 
shaking. The membrane after incubation was washed thrice with 
PBS-Tween-20 (5 minutes each) and incubated with goat anti-
mouse monoclonal antibody (1:3,000) for HIF-1α and goat anti-rabbit 
HRP tagged antibody (1:10,000) for VEGF (in 5 % non-fat milk 
solution) (Santa Cruz Biotechnology, Inc., CA) at RT for 1 hour. After 
incubation, the membrane was washed twice with PBS-Tween-20 (5 
minutes each) and for 10 minutes with the same. The protein bands 
were quantified by autoluminographs. The amount of protein in each 
well was confirmed by stripping the membrane with stripping buffer 
(at 70°C for 1 hour) and reprobing with monoclonal antibody to β-
actin by following the manufacturer’s instruction (Santa Cruz 
Biotechnology, Inc., CA). Immunodetection of the protein 
expressions under study was performed using ECL prime western 
blotting detection reagent (Amersham Biosciences, Piscataway, NJ) 
and visualized in a ChemiDoc XRS system (Bio-Rad Laboratories 
Inc., Hercules, CA). 
 
Statistical Analysis 
 
Results refer to mean ± standard deviation and are average of three 
values per experiment; each experiment was repeated at least three 
times. Statistical evaluations were assessed using the Student’s t 
test, and p < 0.05 was considered significant. 
 
Results 
 
Effect of decoction on enzymes 
 
The decoction treated Hep G2 cells showed an increase in the 
activity of Pyruvate dehydrogenase (PDH) enzyme than the 
untreated cells (Figure 1). In untreated liver cancer cells, PDH 
activity was found to be 0.76 ± 0.07 mU/mL. This PDH activity 
significantly increased to 1.29 ± 0.09, 3.67 ± 0.15 and 4.65 ± 0.11 
mU/mL when treated with 7.5, 15 and 30 μg/mL concentrations of 
the decoction respectively. The activity of the enzyme was found to 
increase nearly 5 folds when treated with 15 μg/mL concentration of 
the decoction. 
 
 
Figure 1. PDH enzyme activity 
 
Figure 2 represents the status of Lactate dehydrogenase A (LDHA) 
enzyme activity in both untreated and decoction treated liver cancer 
(Hep G2) cells. In untreated Hep G2 cells, LDHA activity was found 
to be 1.64 ± 0.04 U/mg protein which decreased to 1.44 ± 0.05, 0.64 
± 0.03 and 0.38 ± 0.04 U/mg protein when treated with 7.5, 15 and 
30 μg/mL concentrations of the decoction respectively. The results 
showed that there was 2.5 times reduction in the activity of the LDHA 
activity when treated with 15 μg/mL concentration of the decoction. 
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Figure 2. LDHA enzyme activity 
 
Effect of decoction on cell viability 
 
Concentration-dependent study performed using MTT assay to 
check the effect of the decoction on the cell viability of normal Chang 
liver cells and Hep G2 liver cancer cells showed that an increase in 
concentration of the decoction (0, 25, 50, 75 and 100 µg/mL) 
selectively reduced the cell viability in the cancer cells at higher 
concentration than normal cells (Fig. 3). Total (100%) growth 
inhibition was observed at a concentration near 100 µg/mL of the 
decoction on the Hep G2 cancer cells whereas this concentration 
produced only 50 % cell death in the normal Chang liver cells which 
showed that the decoction has reduced cytotoxic effect on non-
cancerous normal cells. 
 
Figure 3. Percentage growth inhibition after treatment with decoction 
on Hep G2 and Chang liver cells. x-axis shows concentration in 
µg/mL and y-axis shows percentage of inhibition. 
 
Molecular analysis of the factors in Hep G2 cells 
 
RT-PCR 
 
The mRNA expression level of tumor suppressor p53 from the 
untreated and decoction treated liver cancer cells were found to 
increase whereas the expression of oncogene MYC mRNA was 
found to decrease in the decoction treated Hep G2 cells (Fig. 4); 
which can be compared to the expression of house-keeping protein 
beta-actin providing a relative expression pattern (Fig. 5a and 5b). 
So, it was evident that as the concentration of the decoction 
increased, the expression of tumor suppressor p53 increased and 
the expression of oncogene MYC decreased, which confirmed the 
ability of the decoction to return the overall regulatory mechanism in 
the cancer cell like that in those of normal cells. 
 
 
Figure 4. RT-PCR gel showing expression of p53 and MYC 
genes 
 
 
  Figure 5a. Relative p53 expression normalized to β-actin 
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Figure 5b. Relative MYC expression normalized to β-actin 
 
Western blotting 
 
The protein expression studies of Hypoxia inducible factor-1-alpha 
(HIF-1α) and Vascular endothelial growth factor (VEGF), which 
would lead to angiogenesis and further helping the cancer cells in 
survival and metastasis; showed that the decoction induced 
decreased expression of both the factors (Fig. 6); which can be 
compared to the expression of house-keeping protein beta-actin 
providing a relative expression pattern (Fig. 7a and 7b). As these 
factors play a very significant role in the cancer cell growth and 
metastasis, the decrease in the expression of HIF-1α and VEGF 
could be vital in triggering the cancer cell to revert back to oxidative 
phosphorylation from anaerobic glycolysis and lactic acid 
fermentation. 
 
 
Figure 6. Western blot of Hif-1α and VEGF proteins 
 
 
Figure 7a. Relative Hif-1α expression normalized to β-actin 
 
 
Figure 7b. Relative expression of VEGF normalized to β-actin 
 
Discussion 
 
Cancer cell metabolism is a direct result of the modulation of 
intracellular signaling pathways that are disrupted by mutated 
oncogenes and tumor-suppressor genes. The persistent activation 
of aerobic glycolysis in cancer cells can be linked to activation of 
oncogenes or loss of tumor suppressors, thereby fundamentally 
advancing cancer progression. In this respect, inhibition of glycolytic 
capacity may contribute to an anticancer effect on malignant cells 
and thus, interrupting lactate fermentation and/or other cancer-
promoting metabolic sites may provide a promising strategy to halt 
tumor development. Unlike normal cells that produce energy mostly 
through the oxidation of pyruvate in the mitochondria through 
oxidative phosphorylation, cancer cells predominantly produce 
energy via enhanced glycolysis in the cytosol followed by lactic acid 
fermentation which is regulated mainly by factors like HIF-1α [15]. 
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Natural products have played a very vital role in the prevention, 
treatment and management of diseases in humans from time 
immemorial. Throughout human evolution, the importance of natural 
products has been enormous from being a source of energy as food, 
to being miracle drugs for a plethora of diseases. Turmeric is one 
such spice that has been used worldwide, especially in Indian 
cuisines. It is known to be one of the oldest spices that have been 
used in India for thousands of years and is a major part of Ayurvedic 
medicine. Curcumin, which is isolated from turmeric, has been found 
to possess anticancer activities via its effect on a variety of biological 
pathways involved in mutagenesis, oncogene expression, cell cycle 
regulation, apoptosis, tumorigenesis and metastasis. Curcumin is 
reported to possess anti-bacterial, antioxidant, anti-inflammatory, 
anti-hepatotoxic and anti-tumor properties [16]. Curcumin as a 
natural phytochemicals could communicate with many novel targets 
and show synergism to chemotherapy. Additionally, curcumin is well 
tolerated in humans [17]. Although turmeric has been used in 
cuisines world-wide, one of the problems associated with it, is its low 
bioavailability after it is taken orally. But piperine, a component of 
Black pepper is reported to increase the bioavailability of curcumin 
by 2000 % [18]. Black pepper (Piper nigrum) can be used for 
different purposes such as human dietaries, as medicine, as 
preservatives, as biocontrol agent and as an agent to increase 
bioavailability of other bioactive compounds. This plant and its active 
component piperine can stimulate the digestive enzymes of 
pancreas and intestines and also increases biliary bile acid secretion 
when orally administered. Other activities include anti-inflammatory 
activity, antioxidant activity and chemopreventive activity. 
Medicinally black pepper can be used for digestive disorders like 
large intestine toxins, different gastric problems, diarrhea and 
indigestion [19, 20]. Garlic is yet another spice which is used 
extensively in most cuisines worldwide. Ajoene, a compound 
isolated from garlic has been found to possess antiproliferative 
activity and also preferentially suppresses the growth of neoplastic 
cells [21]. 
Food provides not only essential nutrients needed for life but also 
other bioactive compounds for health promotion and disease 
prevention. Previous epidemiologic studies have consistently shown 
that diet plays a crucial role in the prevention of chronic diseases. 
One of the key issues in this field of research is, however, that 
purified phytochemicals do not necessarily exert the same beneficial 
health effect as when the compound source is in a food or even a 
complete specific diet. Although relatively high doses of single 
bioactive agents may show potent anticarcinogenic effects, the 
chemopreventive properties of interactions among various dietary 
ingredients that potentiate the activities of any single constituent may 
better explain the observed preventive effect of whole foods and 
diets in many epidemiological studies [22]. 
Hot water as the extraction medium was used because water is the 
main medium used to prepare food generally and for diets in case of 
patients suffering from medical conditions. Most foods of plant origin 
contain components which are active regulators of various pathways 
and processes in the human cells. These are mainly compounds of 
natural origin, which are formed by regulated biosynthesis in plants 
[23]. 
Curcumin (diferuoyl methane) is a phenolic compound and a major 
component of Curcuma longa L. Curcumin has been reported to 
regulate various different pathways in a cancer cell. Curcumin is 
found to inhibit the expression of oncogenes including MYC [24]. In 
a study by Bae et al., (2006) it was shown curcumin suppressed the 
transcriptional activity of HIF-1 under hypoxia, leading to a decrease 
in the expression of vascular endothelial growth factor (VEGF), a 
major HIF-1 target angiogenic factor. Curcumin also blocked 
hypoxia-stimulated angiogenesis in vitro and down-regulated HIF-1α 
and VEGF expression in vascular endothelial cells [25, 26]. Piperine, 
a principal bioactive compound present in black pepper, is reported 
to inhibit the proliferation and G1/S transition in endothelial cells 
without causing cell death. It also inhibited the expression of matrix 
metalloproteinase MMP-9, thereby interfering with tumor cell 
migration and invasion [27]. Piperine inhibited the PI3K/Akt signaling 
cascade that promotes angiogenesis [28]. Garlic and garlic derived 
sulphur compounds have shown to alter activation of carcinogens 
and to cause growth inhibition of tumor cells [21]. Several 
mechanisms have been presented to explain cancer 
chemopreventive effects of garlic-derived products. These include 
modulation in activity of several metabolizing enzymes that activate 
and detoxify carcinogens and inhibit DNA adduct formation, 
antioxidative and free radicals scavenging properties and regulation 
of cell proliferation, apoptosis and immune responses. Recent data 
show that garlic-derived products modulate cell-signaling pathways 
in a fashion that controls the unwanted proliferation of cells thereby 
imparting strong cancer chemopreventive as well as cancer 
therapeutic effects [29]. Garlic is reported to possess 12 % Vitamin-
B5 (Pantothenic acid) [30]. Pantothenic acid, which is a precursor for 
the synthesis of coenzyme A, acts as an acyl group carrier to form 
acetyl-coA which is important for the conversion of pyruvate formed 
by glycolysis to enter the TCA cycle and further into the oxidative 
phosphorylation [31]. The garlic in the decoction could thus acts as 
a source of pantothenic acid, which would combine with the pyruvate 
formed in the cancer cell to revert back to TCA cycle and further into 
oxidative phosphorylation rather than entering lactic acid 
fermentation. 
Even though all the spices are reported to possess anti-proliferative 
activity, no study has been conducted till date on the synergistic 
activity of all the three spices in combination, which is commonly 
used in culinary recipes on daily basis world over. Our study shows 
that the spices when used in combination triggered decrease in the 
level of LDHA enzyme and an increase in the level of PDH enzyme 
and also down regulated the expression of HIF-1α and VEGF, 
factors which help cancer cells in their survival, promoting 
angiogenesis and thus resulting in invasion and metastasis (Fig 10). 
The decoction induced considerable lower percentage of cell death 
in normal Chang liver cells thus proving its ability to differentiate 
between normal cells and rapidly dividing cancerous cells. 
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Figure 10. Proposed mechanism of action of the decoction on the cells based on the study 
 
 
 
Conclusion 
 
The growing interest in biological actions of plant extracts is a 
consequence of, among others, an increasingly high incidence of 
various cancers and a need to find safe and effective method for 
prophylaxis and therapy. In this study, the decoction of the spices 
was found to decrease the expression of angiogenesis promoting 
factors and also increase PDH enzyme activity than LDHA activity 
which modifies the cancer cell bioenergetics mechanism to that of 
the normal cells. The decoction induced lower apoptotic activity on 
the normal Chang liver cells showing that the decoction by certain 
means manages to differentiate between normal and cancerous 
cells. The combined activity of aqueous extract of the spices in the 
decoction is found to have a synergistic growth regulatory activity in 
the liver cancer cells. This is the first report on the combined  
 
 
synergistic activity of extract of two or more spices in a decoction on 
shifting the bioenergetics balance in a cancer cell and these findings 
would provide yet another method of targeting cancer cells using 
combination of extracts exploiting their synergistic activity. 
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